NightHawk Biosciences, Inc.
AMEX: NHWK0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- New York Stock Exchange Arca
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Jeffrey Alan Wolf
- Employees
- 77
- Headquarters
- Morrisville, United States
- IPO year
- 2013
- Market cap
- $10.8M
- Website
- https://www.nighthawkbio.com
Loading NHWK…
Loading profile data…Frequently asked questions about NHWK
What does NightHawk Biosciences, Inc. (NHWK) do?
NightHawk Biosciences, Inc. operates as an integrated biopharmaceutical firm, dedicated to advancing immune therapies and vaccines. Their core mission involves leveraging and modifying the body's immune system to combat a range of illnesses, particularly various cancers and infectious diseases. Central to their strategy is the proprietary gp96 p...
Where does NHWK trade?
NightHawk Biosciences, Inc. (NHWK) trades on the New York Stock Exchange Arca.
What sector is NHWK in?
NightHawk Biosciences, Inc. (NHWK) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of NightHawk Biosciences, Inc.?
Jeffrey Alan Wolf is the chief executive officer of NightHawk Biosciences, Inc. (NHWK).
Where is NightHawk Biosciences, Inc. headquartered?
NightHawk Biosciences, Inc. is headquartered in United States.
Does NHWK pay a dividend?
NightHawk Biosciences, Inc. (NHWK) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did NHWK go public?
NightHawk Biosciences, Inc. (NHWK) completed its initial public offering in 2013.